electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Group 1 - electroCore, Inc. announced the appointment of Seth Abrams as VP of Sales effective April 1, 2026, and Michael Fox as Chief Operating Officer effective April 13, 2026 [1] - The Compensation Committee granted 30,000 restricted stock units (RSUs) to Mr. Abrams and 70,000 RSUs to Mr. Fox as part of their employment inducement [1] - The RSUs will vest in three equal parts on the first, second, and third anniversaries of the grant date, contingent on continued employment [1] Group 2 - electroCore, Inc. is a commercial-stage bioelectronic technology company focused on improving health and quality of life through non-invasive bioelectronic technologies [2] - The company's leading products include gammaCore for chronic pain treatment and Quell® for fibromyalgia, utilizing non-invasive neuromodulation technology [2] - electroCore also markets handheld products like Trvuaga and TAC-STIM for general wellness and human performance enhancement [2]